[go: up one dir, main page]

WO2020097576A1 - Éclairage bioactif commutable - Google Patents

Éclairage bioactif commutable Download PDF

Info

Publication number
WO2020097576A1
WO2020097576A1 PCT/US2019/060636 US2019060636W WO2020097576A1 WO 2020097576 A1 WO2020097576 A1 WO 2020097576A1 US 2019060636 W US2019060636 W US 2019060636W WO 2020097576 A1 WO2020097576 A1 WO 2020097576A1
Authority
WO
WIPO (PCT)
Prior art keywords
blue
red
light
color
long
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2019/060636
Other languages
English (en)
Inventor
Raghuram L.V. Petluri
Paul Kenneth Pickard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ecosense Lighting Inc
Original Assignee
Ecosense Lighting Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2019/013359 external-priority patent/WO2019140309A1/fr
Priority claimed from PCT/US2019/013380 external-priority patent/WO2019140327A2/fr
Priority claimed from PCT/US2019/013379 external-priority patent/WO2019140326A1/fr
Priority claimed from PCT/US2019/013356 external-priority patent/WO2019140306A1/fr
Application filed by Ecosense Lighting Inc filed Critical Ecosense Lighting Inc
Publication of WO2020097576A1 publication Critical patent/WO2020097576A1/fr
Anticipated expiration legal-status Critical
Priority to US17/316,264 priority Critical patent/US20220001200A1/en
Priority to US18/103,184 priority patent/US11938339B2/en
Priority to US18/617,143 priority patent/US20240416142A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0618—Psychological treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
    • H05B45/00—Circuit arrangements for operating light-emitting diodes [LED]
    • H05B45/20—Controlling the colour of the light
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
    • H05B47/00—Circuit arrangements for operating light sources in general, i.e. where the type of light source is not relevant
    • H05B47/10—Controlling the light source
    • H05B47/105—Controlling the light source in response to determined parameters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/065—Light sources therefor
    • A61N2005/0651—Diodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light

Definitions

  • Color rendering performance may be characterized via standard metrics known in the art.
  • Fidelity Index (Rf) and the Gamut Index (Rg) can be calculated based on the color rendition of a light source for 99 color evaluation samples (“CES”).
  • the 99 CES provide uniform color space coverage, are intended to be spectral sensitivity neutral, and provide color samples that correspond to a variety of real objects.
  • Rf values range from 0 to 100 and indicate the fidelity with which a light source renders colors as compared with a reference illuminant. In practical terms, the Rf is a relative measure of the shift in surface color of an object when lit by a particular lamp as compared to a reference light source, typically either a black-body radiator or the daylight spectrum.
  • LEDs have the potential to exhibit very high power efficiencies relative to conventional incandescent or fluorescent lights. Most LEDs are substantially monochromatic light sources that appear to emit light having a single color. Thus, the spectral power distribution of the light emitted by most LEDs is tightly centered about a“peak” wavelength, which is the single wavelength where the spectral power distribution or“emission spectrum” of the LED reaches its maximum as detected by a photo-detector. LEDs typically have a full- width half-maximum wavelength range of about 10 nm to 30 nm, comparatively narrow with respect to the broad range of visible light to the human eye, which ranges from approximately from 380 nm to 800 nm.
  • FIG 2 illustrates aspects of light emitting devices according to the present disclosure
  • FIG 5 illustrates some aspects of light emitting devices according to the present disclosure, including some suitable color ranges for light generated by components of the devices;
  • FIG 15 illustrates some aspects of light emitting devices according to the present disclosure in comparison with some prior art and some theoretical light sources, including some light characteristics of white light generated by light emitting devices in various operational modes;
  • LRNE may be beneficial by reducing, limiting, counteracting or ameliorating some of the negative effects associated with excessive blue light exposure.
  • Disclosed herein are methods and systems to provide therapeutic doses of LRNE either to address a biological condition or as a prophylactic or health supplement means to limit or prevent at least one of an emotional, neurological, immune, and biological condition or system.
  • “Bioactive Exposure” refers to one or both of LRNE and CSE and directing at least one of LRNE and CSE at a biological system which may be a specific organ or any part of the body [0070]
  • the Bioactive Exposure may be controlled by a control system (described herein, see e.g., FIG.
  • LRNE exposure may lead to improved cognitive function with few side effects.
  • those exposed to LRNE experienced quicker reaction times, better memory, a more positive mood, and the ability to leam new information faster.
  • These beneficial effects on the human brain may be related to LRNE’s increasing cerebral blood flow and oxygen availability and boost ATP energy production. Hennessy, M., & Hamblin,
  • the luminescent materials may comprise phosphors comprising one or more of the following materials: CaAlSiN3:Eu, BaMgAl10O17:Eu, Lu3Al5O12:Ce, or Y3Al5O12:Ce.
  • LRNE emissions can be generated with one or more luminescent materials that generate emissions with wavelengths between about 625 nm and about 1400 nm.
  • the luminescent materials can comprise phosphors comprising one or more of the materials listed above.
  • TLCI-2012 Television Lighting Consistency Index
  • EBU European Broadcasting Union
  • EBU Tech 3355-sl An Introduction to Spectroradiometry, which are incorporated by reference herein in their entirety, including all appendices, for all purposes.
  • the TLCI compares the test light source to a reference luminaire, which is specified to be one whose chromaticity falls on either the Planckian or Daylight locus and having a color temperature which is that of the CCT of the test light source.
  • a cyan color range 303B can be defined by the region bounded by lines connecting (0.360, 0.495), (0.371, 0.518), (0.388, 0.522), and (0.377, 0.499).
  • FIG. 6 depicts some further color ranges suitable for some implementations of the disclosure.
  • a cyan color range 303C is defined by a line connecting the ccx, ccy color coordinates (0.18, 0.55) and (0.27, 0.72), the constant CCT line of 9000K, the Planckian locus between 9000K and 4600K, the constant CCT line of 4600K, and the spectral locus.
  • a cyan color range 303D is defined by the constant CCT line of 4600K, the spectral locus, the constant CCT line of 1800K, and the Planckian locus between 4600K and 1800K.
  • the long-blue-pumped cyan channel can have a spectral power distribution with spectral power in one or more of the wavelength ranges other than the reference wavelength range increased or decreased within 30% greater or less, within 20% greater or less, within 10% greater or less, or within 5% greater or less than the values shown in Table 3 and 4.
  • the red channel can produce red light having certain spectral power distributions. Tables 3-4 and 7-9 show the ratios of spectral power within wavelength ranges, with an arbitrary reference wavelength range selected for the red color range and normalized to a value of 100.0, for red lighting channels, long-red lighting channels, and LRNE channels that may be used in some implementations of the disclosure.
  • the yellow channel can have a spectral power distribution with the relative ratios of intensity between particular pairs of the peak and valley intensities increased or decreased within 30% greater or less, within 20% greater or less, within 10% greater or less, or within 5% greater or less than the relative ratio values for one or more of Yellow Channels 1-6 and the Exemplary Yellow Channels Average shown in Table 41.
  • the devices can be configured to generate the fifth unsaturated light corresponding to a plurality of points along a predefined path with the light generated at each point having one or more of EML greater than or equal to about 0.45 along points with correlated color temperature above about 2100K, EML greater than or equal to about 0.55 along points with correlated color temperature above about 2400K, EML greater than or equal to about 0.7 along points with correlated color temperature above about 3000K EML greater than or equal to about 0.9 along points with correlated color temperature above about 4000K, and EML greater than or equal to about 1.1 along points with correlated color temperature above about 6000K.
  • the blue color region can comprise a region on the 1931 CIE Chromaticity Diagram defined by a line connecting the ccx, ccy color coordinates of the infinity point of the Planckian locus (0.242, 0.24) and (0.12, 0.068), the Planckian locus from 4000K and infinite CCT, the constant CCT line of 4000K, the line of purples, and the spectral locus.
  • the short-blue-pumped cyan color region, long-blue-pumped cyan color region, or both can comprise a region on the 1931 CIE
  • Each LED string was simulated with an LED emission spectrum and excitation and emission spectra of luminophoric medium(s).
  • luminophoric mediums comprising phosphors
  • the simulations also included the absorption spectrum and particle size of phosphor particles.
  • the LED strings generating combined emissions with color points within the yellow and violet regions were simulated using spectra of LEDs having peak wavelengths of between about 380 nm and about 420 nm, such as one or more 410 nm peak wavelength violet LEDs, one or more LUXEON Z UV LEDs (product codes LHUV-0380-, LHUV-0385- , LHUV-0390-, LHUV-0395-, LHUV-0400-, LHUV-0405-, LHUV-0410-, LHUV-0415-, LHUV-0420-,) (Lumileds Holding B.V., Amsterdam, Netherlands), one or more LUXEON UV FC LEDs (product codes LxF3-U4lO) (Lumileds Holding B.V., Amsterdam,
  • a sixth LED string is driven by a violet LED having peak emission wavelength of about 400 nm, utilizes a recipient luminophoric medium, and generates a combined emission of a violet channel having the color point and characteristics of Violet Channel 2 as described above and shown in Tables 5 and 10-12.
  • a sixth LED string is driven by a violet LED having peak emission wavelength of about 410 nm, utilizes a recipient luminophoric medium, and generates a combined emission of a violet channel having the color point and characteristics of Violet Channel 3 as described above and shown in Tables 5 and 10-12.
  • the platform may be configured to change settings or parameters for a lighting installation (including but not limited to panel systems of the present disclosure, such as by using a custom tuning system) based on a variety of real time data, with a view to having the lighting installation, including panel systems included therein, best suit its environment in a dynamic way.
  • data may be obtained that serves as an indicator of the emotional state or the stress level of an environment, and the lighting installation may respond accordingly to that state or stress level.
  • data about the environment may be collected by a wearable device 3333, such as a smartwatch, armband, or the like; for example, data may be collected on acceleration, location, ambient light characteristics, and heart rate, among other possibilities.
  • wearable or physiological sensors may sense one or more of a person' s temperature, blood pressure, heart rate, oxygen saturation, activity type, activity level, galvanic skin response, respiratory rate, cholesterol level (including HDL, LDL and triglyceride), hormone or adrenal levels (e.g., Cortisol, thyroid, adrenaline, melatonin, and others), histamine levels, immune system characteristics, blood alcohol levels, drug content, macro and micro nutrients, mood, emotional state, alertness, sleepiness, and the like.
  • hormone or adrenal levels e.g., Corti
  • s_M750_rb4_M630_yag LiAl02:Fe 3+ (peak at 770nms), CdS:Ag + ,Cl (peak at 800nms), ZnSbGaTe:Cr 3+ ,Nd 3+ (peak at 845nms), La 3 ln 2 Ga 3 O 12 :Cr 3+ , Dy 3+ (peak at 905nms),
  • Computer storage media includes volatile and nonvolatile, removable and non-removable, tangible and non-transient media, implemented in any method or technology for storage of information such as computer-readable instructions, data structures, program modules or other data.
  • Computer storage media includes RAM; ROM; EE-PROM; flash memory or other memory technology; CD-ROMs; DVDs or other optical disk storage;
  • a network set up by an entity, such as a company or a public sector organization, to provide one or more web services (such as various types of cloud-based computing or storage) accessible via the Internet and/or other networks to a distributed set of clients may be termed a provider network.
  • a provider network may include numerous data centers hosting various resource pools, such as collections of physical and/or virtualized computer servers, storage devices, networking equipment, and the like, needed to implement and distribute the infrastructure and web services offered by the provider network.
  • the resources may in some embodiments be offered to clients in various units related to the web service, such as an amount of storage capacity for storage, processing capability for processing, as instances, as sets of related services, and the like.
  • the panel 3310 systems are installed in the environment of a lighting installation, networking features automatically engage upon powering up one or more the panel systems, and the panel systems may automatically commission themselves, such as by connecting to an overall control platform and/or to other panel systems.
  • the panel systems in an installation may self-commission and self- configure to create a network connection between the panel systems in the environment and a remote operator (such as in the cloud).
  • the panel systems may configure in a master/slave, ring, mesh, or peer-to-peer network, by which autonomous control features may be engaged in the environment.
  • remote control features may be engaged using the network connection to the platform or other remote operators.
  • the remote-control interface may use a lighting project data structure as a source of knowledge about the properties, configurations, control capabilities, and other elements of a lighting installation, so that the same platform used for the design of the lighting installation may be used to control the lighting installation.
  • the remote-control interface may include operational guidance features, such as guiding users through the operation of a lighting installation.
  • remote control may enable field programmable lighting systems, such as for transitional environments like museums (where art objects change regularly), stores (where merchandise shifts) and the like as well as for customizable environments (such as personalizing lighting in a hotel room according to a specification for a guest (which may include having the guest select an aesthetic filter) or personalized lighting for a workstation for an employee in an office setting, or personalized wearable systems.
  • field programmable lighting systems such as for transitional environments like museums (where art objects change regularly), stores (where merchandise shifts) and the like as well as for customizable environments (such as personalizing lighting in a hotel room according to a specification for a guest (which may include having the guest select an aesthetic filter) or personalized lighting for a workstation for an employee in an office setting, or personalized wearable systems.
  • external inputs may include, but are not limited to audible, tactile, sensory, and user information through one or more sensors and other means, depending on the external system and its capabilities.
  • external systems and external information may also comprise the same types systems and information discussed below and in various embodiments herein.
  • control capabilities of the panel systems may include dynamic configuration of control parameters, such as providing a dimming curve for a light source, including but not limited to a panel system of the present disclosure, that is customized to the preferences of a designer or other user. This may include a selection from one or more modes, such as ones described elsewhere herein that have desired effects on mood or aesthetic factors, that have desired health effects, that meet the functional requirements, or the like.
  • machine learning may be used, such as based on various feedback measures, such as relating to mood (stated by the user or measured by one or more sensors), noise levels (such as indicating successful utilization of a space based on a desired level of noise), returns on investment (such as where panel systems are intended to promote retail merchandise), reported pain levels, measured health levels, performance levels of users (including fitness, wellness, and educational performance, among others), sleep levels, vitamin D levels, melatonin levels, and many others.
  • various feedback measures such as relating to mood (stated by the user or measured by one or more sensors), noise levels (such as indicating successful utilization of a space based on a desired level of noise), returns on investment (such as where panel systems are intended to promote retail merchandise), reported pain levels, measured health levels, performance levels of users (including fitness, wellness, and educational performance, among others), sleep levels, vitamin D levels, melatonin levels, and many others.
  • the lighting installations including the panel systems may be operated or controlled based on external information, such as based on seasonal lighting conditions, weather, climate, collective mood indicators (such as based on stock market data, news feeds, or sentiment indices), analyses of social network data, and the like. This may include controlling a system to reflect, or influence, the mood of occupants.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Developmental Disabilities (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Social Psychology (AREA)
  • Circuit Arrangement For Electric Light Sources In General (AREA)
  • Radiation-Therapy Devices (AREA)
  • Led Device Packages (AREA)

Abstract

La présente invention concerne des systèmes d'éclairage, qui peuvent comprendre des dispositifs électroluminescents à semi-conducteur, possédant au moins deux canaux bleus, rouges et/ou LRNE, cyan à pompage bleu court, cyan à pompage bleu long, jaunes et violets. Les systèmes d'éclairage peuvent comprendre une pluralité de modes de fonctionnement qui produisent différents effets biologiques tout en présentant une bonne capacité de rendu des couleurs. Les canaux jaunes et violets peuvent comprendre des DEL à UV et être utilisés dans des modes de fonctionnement qui produisent une lumière blanche présentant des valeurs EML inférieures par rapport à des modes de fonctionnement utilisant au moins trois canaux bleus, rouges, cyan à pompage bleu court, et cyan à pompage bleu long.
PCT/US2019/060636 2018-11-08 2019-11-08 Éclairage bioactif commutable Ceased WO2020097576A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US17/316,264 US20220001200A1 (en) 2018-11-08 2021-05-10 Switchable bioactive lighting
US18/103,184 US11938339B2 (en) 2018-11-08 2023-01-30 Switchable bioactive lighting
US18/617,143 US20240416142A1 (en) 2018-11-08 2024-03-26 Switchable bioactive lighting

Applications Claiming Priority (20)

Application Number Priority Date Filing Date Title
US201862757672P 2018-11-08 2018-11-08
US201862757664P 2018-11-08 2018-11-08
US62/757,664 2018-11-08
US62/757,672 2018-11-08
US201862758411P 2018-11-09 2018-11-09
US201862758447P 2018-11-09 2018-11-09
US62/758,447 2018-11-09
US62/758,411 2018-11-09
PCT/US2019/013359 WO2019140309A1 (fr) 2018-01-11 2019-01-11 Systèmes commutables pour lumière blanche à haut rendu de couleurs et à effets biologiques
USPCT/US2019/013380 2019-01-11
PCT/US2019/013380 WO2019140327A2 (fr) 2018-01-11 2019-01-11 Systèmes d'éclairage d'affichage à effets circadiens
PCT/US2019/013379 WO2019140326A1 (fr) 2018-01-11 2019-01-11 Systèmes de panneau à éclairage circadien
USPCT/US2019/013356 2019-01-11
PCT/US2019/013356 WO2019140306A1 (fr) 2018-01-11 2019-01-11 Systèmes d'éclairage accordable à deux canaux avec des sorties à lux mélanopique équivalent et température de couleur corrélée contrôlables
USPCT/US2019/013359 2019-01-11
USPCT/US2019/013379 2019-01-11
US16/393,660 US10805998B2 (en) 2018-01-11 2019-04-24 Display lighting systems with circadian effects
US16/393,660 2019-04-24
US201962885162P 2019-08-09 2019-08-09
US62/885,162 2019-08-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US16/393,660 Continuation-In-Part US10805998B2 (en) 2018-01-11 2019-04-24 Display lighting systems with circadian effects

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US17/316,264 Continuation US20220001200A1 (en) 2018-11-08 2021-05-10 Switchable bioactive lighting

Publications (1)

Publication Number Publication Date
WO2020097576A1 true WO2020097576A1 (fr) 2020-05-14

Family

ID=70610741

Family Applications (4)

Application Number Title Priority Date Filing Date
PCT/US2019/060642 Ceased WO2020097580A1 (fr) 2018-11-08 2019-11-08 Systèmes de panneau d'éclairage bioactif
PCT/US2019/060640 Ceased WO2020097579A1 (fr) 2018-11-08 2019-11-08 Systèmes d'éclairage d'affichage à éclairage bioactif
PCT/US2019/060634 Ceased WO2020097575A1 (fr) 2018-11-08 2019-11-08 Éclairage bioactif multicanal
PCT/US2019/060636 Ceased WO2020097576A1 (fr) 2018-11-08 2019-11-08 Éclairage bioactif commutable

Family Applications Before (3)

Application Number Title Priority Date Filing Date
PCT/US2019/060642 Ceased WO2020097580A1 (fr) 2018-11-08 2019-11-08 Systèmes de panneau d'éclairage bioactif
PCT/US2019/060640 Ceased WO2020097579A1 (fr) 2018-11-08 2019-11-08 Systèmes d'éclairage d'affichage à éclairage bioactif
PCT/US2019/060634 Ceased WO2020097575A1 (fr) 2018-11-08 2019-11-08 Éclairage bioactif multicanal

Country Status (1)

Country Link
WO (4) WO2020097580A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021142292A1 (fr) 2020-01-08 2021-07-15 Ecosense Lighting Inc. Systèmes et procédés d'éclairage d'un dispositif d'affichage sur papier électronique
CA3197898A1 (fr) * 2020-11-09 2022-05-12 Andrew J. ZELE Dispositif, procede et systeme d'eclairage equilibre biologiquement
GB202115364D0 (en) * 2021-10-26 2021-12-08 Five Create Ltd Apparatus for emitting light for therapeutic purposes
EP4186560A1 (fr) * 2021-11-26 2023-05-31 Seaborough Life Science B.V. Dispositif d'irradiation électro-optique
DE112023000628T5 (de) * 2022-01-20 2024-11-21 Korrus, Inc. Lichttherapie-System und Verfahren
EP4268708A1 (fr) * 2022-04-28 2023-11-01 Tridonic GmbH & Co. KG Module d'éclairage
US12377286B2 (en) 2023-01-26 2025-08-05 Suninlyf Bio Inc. Anti-infective and therapeutic electromagnetic emission methods and devices
WO2026021907A1 (fr) 2024-07-24 2026-01-29 Signify Holding B.V. Source de lumière à haute efficacité à indice d'observation de cyanose très faible

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070205712A1 (en) * 2005-02-02 2007-09-06 Lumination, Llc Red line emitting phosphors for use in LED applications
US20120330387A1 (en) * 2010-01-21 2012-12-27 Koninklijke Philips Electronics N.V. Control device, wearable device and lighting system for light therapy purposes
US20170086274A1 (en) * 2015-09-15 2017-03-23 Biological Innovation & Optimization Systems, LLC Systems and methods for controlling the spectral content of led lighting devices
US20170105265A1 (en) * 2014-05-27 2017-04-13 Laurence P. Sadwick Lighting Systems
US20170231058A1 (en) * 2014-08-04 2017-08-10 Innosys, Inc. Lighting Systems
US20170356624A1 (en) * 2016-01-28 2017-12-14 Ecosense Lighting Inc Compositions for led light conversions
US20180056027A1 (en) * 2015-03-19 2018-03-01 Philips Lighting Holding B.V. Bio hue lamp

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080275533A1 (en) * 2007-05-04 2008-11-06 Powell Steven D Display apparatus for providing information and therapeutic light
MY154234A (en) * 2008-07-08 2015-05-15 Proteus Digital Health Inc Ingestible event marker data framework
WO2012024243A1 (fr) * 2010-08-16 2012-02-23 Photothera, Inc. Photothérapie de faible intensité mini-invasive pour des troubles neurologiques
US10328276B2 (en) * 2014-02-14 2019-06-25 Applied Biophotonics Ltd. Sinusoidal drive system and method for phototherapy
US9410664B2 (en) * 2013-08-29 2016-08-09 Soraa, Inc. Circadian friendly LED light source
KR102222254B1 (ko) * 2015-06-24 2021-03-04 가부시끼가이샤 도시바 백색 광원 시스템
EP3466218A4 (fr) * 2016-06-03 2020-01-22 Musco Corporation Appareil, procédé et système de fourniture d'un éclairage circadien accordable à une luminosité et une couleur perçues constantes
US10632214B2 (en) * 2016-06-24 2020-04-28 Soraa, Inc. Bactericidal light source with high quality of light
US11338107B2 (en) * 2016-08-24 2022-05-24 Delos Living Llc Systems, methods and articles for enhancing wellness associated with habitable environments
US10595376B2 (en) * 2016-09-13 2020-03-17 Biological Innovation & Optimization Systems, LLC Systems and methods for controlling the spectral content of LED lighting devices
CN113597048B (zh) * 2016-12-05 2024-07-30 路创技术有限责任公司 用于控制色温的系统和方法
WO2018130403A1 (fr) * 2017-01-12 2018-07-19 Philips Lighting Holding B.V. Système d'éclairage qui maintient la dose mélanopique pendant une gradation ou un réglage de couleur

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070205712A1 (en) * 2005-02-02 2007-09-06 Lumination, Llc Red line emitting phosphors for use in LED applications
US20120330387A1 (en) * 2010-01-21 2012-12-27 Koninklijke Philips Electronics N.V. Control device, wearable device and lighting system for light therapy purposes
US20170105265A1 (en) * 2014-05-27 2017-04-13 Laurence P. Sadwick Lighting Systems
US20170231058A1 (en) * 2014-08-04 2017-08-10 Innosys, Inc. Lighting Systems
US20180056027A1 (en) * 2015-03-19 2018-03-01 Philips Lighting Holding B.V. Bio hue lamp
US20170086274A1 (en) * 2015-09-15 2017-03-23 Biological Innovation & Optimization Systems, LLC Systems and methods for controlling the spectral content of led lighting devices
US20170356624A1 (en) * 2016-01-28 2017-12-14 Ecosense Lighting Inc Compositions for led light conversions

Also Published As

Publication number Publication date
WO2020097579A1 (fr) 2020-05-14
WO2020097580A1 (fr) 2020-05-14
WO2020097575A1 (fr) 2020-05-14

Similar Documents

Publication Publication Date Title
US12225650B2 (en) Dynamic display lighting systems with bioactive lighting
US11308849B2 (en) Display lighting systems with circadian effects
US11783748B2 (en) Display lighting systems with bioactive lighting
US11938339B2 (en) Switchable bioactive lighting
WO2020097576A1 (fr) Éclairage bioactif commutable
US20250135222A1 (en) Multi-channel bioactive lighting
US20210060353A1 (en) Panel systems with circadian lighting
US10492264B2 (en) Lighting systems for providing tunable white light with functional diode emissions
US10721802B2 (en) Lighting systems for providing tunable white light with functional diode emissions
WO2019140309A1 (fr) Systèmes commutables pour lumière blanche à haut rendu de couleurs et à effets biologiques
US20220272806A1 (en) Led lighting channels having spectral power distribution characteristics and related multi-channel tunable white lighting systems
KR100973078B1 (ko) 발광 다이오드를 이용한 조명 장치 및 이를 이용한 색온도 제어방법
WO2019140306A1 (fr) Systèmes d'éclairage accordable à deux canaux avec des sorties à lux mélanopique équivalent et température de couleur corrélée contrôlables
US20240090096A1 (en) Switchable systems for white light with high color rendering and biological effects
US20250140171A1 (en) Display lighting systems with bioactive lighting
US20220005404A1 (en) Bioactive panel lighting systems
US20240312384A1 (en) Display lighting systems with circadian effects
WO2019035832A1 (fr) Procédés pour générer de la lumière blanche accordable à haut rendu des couleurs

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19882724

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19882724

Country of ref document: EP

Kind code of ref document: A1